title: Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir.
authors.forename: Amy G
authors.initials: AG
authors.lastname: Cutrell
authors.forename: Jaime E
authors.initials: JE
authors.lastname: Hernandez
authors.forename: Julie W
authors.initials: JW
authors.lastname: Fleming
authors.forename: Mark T
authors.initials: MT
authors.lastname: Edwards
authors.forename: Martha Anne
authors.initials: MA
authors.lastname: Moore
authors.forename: Cindy H
authors.initials: CH
authors.lastname: Brothers
authors.forename: Trevor R
authors.initials: TR
authors.lastname: Scott
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects*; D044383:Black People; D015224:Dideoxynucleosides / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000453:epidemiology* / Q000208:ethnology; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D012189:Retrospective Studies; D012307:Risk Factors; D000099227:Abacavir
chemical_list: D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D000099227:Abacavir